Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Exercise-induced asthma

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44335   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    24 result(s) found for: Exercise-induced asthma. Displaying page 1 of 2.
    1  2  Next»
    EudraCT Number: 2011-003652-39 Sponsor Protocol Number: 30689 Start Date*: 2012-09-17
    Sponsor Name:Karen Schow Jensen
    Full Title: Exercise induced bronchoconstriction in children – a single dose of montelukast as alternative to regular daily doses.
    Medical condition: Exercise induced asthma
    Disease: Version SOC Term Classification Code Term Level
    18.1 100000004855 10015649 Exercise induced asthma LLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: DK (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2005-004984-43 Sponsor Protocol Number: MONTEIA Start Date*: 2005-11-14
    Sponsor Name:UNIVERSITA DEGLI STUDI DI UDINE
    Full Title: Randomized, double-blind, placebo controlled trial on the efficacy of montelukast in exercise-induced asthma in children
    Medical condition: exercise-induced asthma
    Disease: Version SOC Term Classification Code Term Level
    6.1 10003557 PT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2010-018937-23 Sponsor Protocol Number: SD-QVAR Start Date*: 2010-05-31
    Sponsor Name:Medisch Spectrum Twente
    Full Title: The predictive value of the acute effect of beclomethasone on a mannitol challenge test for the outcome of lomgterm treatment with beclomethasone
    Medical condition: Exercise induced asthma / bronchoconstriction Asthma
    Disease: Version SOC Term Classification Code Term Level
    12.1 10015649 Exercise induced asthma LLT
    12.1 10003553 Asthma PT
    12.1 10066091 Bronchial hyperreactivity PT
    Population Age: Adolescents, Under 18 Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-016904-21 Sponsor Protocol Number: SD-MLK Start Date*: 2010-04-22
    Sponsor Name:Medisch Spectrum Twente
    Full Title: The predictive value of the acute effect of montelukast on an exercise challenge test for the outcome of longterm treatment with montelukast
    Medical condition: Exercise induced asthma / bronchoconstriction Asthma
    Disease: Version SOC Term Classification Code Term Level
    12.0 10015649 Exercise induced asthma LLT
    12.0 10066091 Bronchial hyperreactivity LLT
    12.0 10003553 Asthma PT
    Population Age: Adolescents, Under 18 Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-010563-17 Sponsor Protocol Number: FF1 Start Date*: 2009-10-02
    Sponsor Name:Stichting Pediatrisch Onderzoek Enschede
    Full Title: The protective effect of a nasal corticosteroid (Avamys) on exercise induced airway obstruction in cold air.
    Medical condition: Exercise induced airway obstruction
    Disease: Version SOC Term Classification Code Term Level
    9.1 10003557 Asthma exercise induced LLT
    9.1 10001723 Allergic rhinitis LLT
    Population Age: Adolescents, Under 18 Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-012805-20 Sponsor Protocol Number: D5890L00032 Start Date*: 2009-06-29
    Sponsor Name:AstraZeneca AB
    Full Title: A randomised, double blind, placebo controlled, parallel-group study with use of budesonide/formoterol “as-needed”, or terbutaline “as-needed” or regular use of budesonide + terbutaline “as-needed”...
    Medical condition: Exercise induced bronchoconstriction
    Disease: Version SOC Term Classification Code Term Level
    9.1 10015649 Exercise induced asthma LLT
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: View results
    EudraCT Number: 2007-002553-23 Sponsor Protocol Number: H-00982-3256 Start Date*: 2007-10-10
    Sponsor Name:MEDA Pharma GmbH & Co. KG [...]
    1. MEDA Pharma GmbH & Co. KG
    2. MEDA Pharma GmbH & Co. KG
    3. MEDA Pharma GmbH & Co. KG
    4. MEDA Pharma GmbH & Co. KG
    Full Title: Clinical trial to assess the protective effect of the fixed drug combination of disodium cromoglycate plus reproterol in comparison to the single components and placebo in adults with exercise indu...
    Medical condition: Exercise induced asthma
    Disease: Version SOC Term Classification Code Term Level
    9.1 10015649 Exercise induced asthma LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2018-001120-18 Sponsor Protocol Number: DYM Start Date*: 2019-01-17
    Sponsor Name:Stichting Pediatrisch Onderzoek Enschede
    Full Title: The protective effect of azelastine/fluticasone propionate (Dymista) on exercise-induced airway obstruction
    Medical condition: Exercise-induced airway obstruction Asthma Allergic rhinitis
    Disease:
    Population Age: Adolescents, Under 18 Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2012-003600-12 Sponsor Protocol Number: 12001 Start Date*: 2012-10-29
    Sponsor Name:Sportmedisch expertisecentrum
    Full Title: The effect of cold air on the airways of elite skaters and the protective role of the OMRON
    Medical condition: Exericise induced bronchoconstriction
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-001908-23 Sponsor Protocol Number: 13-5-23-9-3-8-15 Start Date*: 2008-06-20
    Sponsor Name:Rigshospitalet, Department of Clinical Pharmacology
    Full Title: A randomised, double blinded, crossover study of the influence of Metoprolol on exercise induced elevation of catecholamines in healthy subjects.
    Medical condition: The medical condition to be investigated is heart failure, but this specific study is made on healthy volunteers to investigate the influence of metoprolol on exercise induced elevation of catechol...
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2019-003606-27 Sponsor Protocol Number: s63147 Start Date*: 2020-02-19
    Sponsor Name:UZ/KU Leuven
    Full Title: WP3-Influence of cromones on EVH-test in young elite athletes who tested positive for EIB.
    Medical condition: Exercise-induced bronchoconstriction (EIB)
    Disease:
    Population Age: Adolescents, Under 18 Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2016-002276-27 Sponsor Protocol Number: PVSD-ICS Start Date*: 2016-08-04
    Sponsor Name:Medisch Spectrum Twente
    Full Title: The predictive value of the acute effect of beclomethasone-dipropionate on a mannitol challenge test for the outcome of longterm treatment with beclomethasone-dipropionate in childhood asthma
    Medical condition: exercise induced bronchoconstriction asthma
    Disease: Version SOC Term Classification Code Term Level
    19.0 10038738 - Respiratory, thoracic and mediastinal disorders 10003553 Asthma PT
    Population Age: Adolescents, Under 18 Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2004-004709-53 Sponsor Protocol Number: 911 Start Date*: 2005-12-05
    Sponsor Name:Merck Sharp & Dohme OÜ
    Full Title: A Multicenter, Double-Blind, Randomized, Cross-Over Design Study to Evaluate the Effect of Montelukast vs. Salmeterol on the Inhibition of Excercise-Induced Bronchoconstriction in Asthmatic Patient...
    Medical condition: Asthma
    Disease: Version SOC Term Classification Code Term Level
    8.0 10003553 LLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: EE (Completed) ES (Completed) IT (Completed) Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2013-002769-20 Sponsor Protocol Number: NL45149.044.13 Start Date*: 2013-09-04
    Sponsor Name:Medisch Spectrum Twente
    Full Title: The protective effect of a single dose salbutamol against exercise induced inspiratory airflow obstruction in asthmatic children.
    Medical condition: Exercise induced bronchoconstriction
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2013-002722-23 Sponsor Protocol Number: NL44755.044.13 Start Date*: 2013-07-09
    Sponsor Name:Medisch Spectrum Twente
    Full Title: The protective effect of a single dose inhaled steroid with different body postures against exercise induced bronchoconstriction
    Medical condition: Exercise Induced Bronchoconstriction
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2017-001516-11 Sponsor Protocol Number: 201832 Start Date*: 2017-07-10
    Sponsor Name:GlaxoSmithKline Research & Development Limited
    Full Title: 201832: A Randomised, Double-Blind, Double-Dummy, Crossover Comparison of Fluticasone Furoate/Vilanterol 100/25 mcg Once Daily Versus Fluticasone Propionate 250 mcg Twice Daily in Adolescent and Ad...
    Medical condition: Adolescent and Adult Subjects with Asthma and Exercise-Induced Bronchoconstriction
    Disease: Version SOC Term Classification Code Term Level
    20.0 10038738 - Respiratory, thoracic and mediastinal disorders 10003553 Asthma PT
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2015-002384-42 Sponsor Protocol Number: MRINZ/15/A1 Start Date*: 2016-10-06
    Sponsor Name:Medical Research Institute of New Zealand
    Full Title: Randomised Controlled Trial of the efficacy and safety of an ICS/LABA reliever therapy regimen in asthma.
    Medical condition: Asthma.
    Disease: Version SOC Term Classification Code Term Level
    19.0 10038738 - Respiratory, thoracic and mediastinal disorders 10003553 Asthma PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2007-004879-19 Sponsor Protocol Number: 0476-377 Start Date*: 2008-02-08
    Sponsor Name:Merck & Co., Inc.
    Full Title: A Double-Blind, Placebo-Controlled, Multicenter, Crossover Study to Evaluate the Effects of a Single Oral Dose of Montelukast, Compared With Placebo, on Exercise-Induced Bronchoconstriction (EIB) i...
    Medical condition: Exercise Induced Bronchoconstriction (EIB)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10006464 Bronchoconstriction LLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: EE (Completed)
    Trial results: View results
    EudraCT Number: 2008-000670-20 Sponsor Protocol Number: BUB2008JE Start Date*: 2009-05-11
    Sponsor Name:Respitatory and Allergy Research Unit
    Full Title: Blood- and urinary concentrations of salbutamol in asthmatics and elite athletes with asthma; comparison between inhalation vs. oral administration.
    Medical condition: The purpose of this study is to assess the plasma and urine concentrations of salbutamol and evaluate the difference between inhaled og oral administration in three groups; healthy men, asthmatics ...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10003560 Asthma NOS LLT
    Population Age: Adults Gender: Male
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2016-001607-23 Sponsor Protocol Number: EFC14153 Start Date*: 2017-06-30
    Sponsor Name:Sanofi-Aventis Recherche & Développement
    Full Title: A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Children 6 to <12 Years of Age with Uncontrolled Persistent Asthma
    Medical condition: Asthma
    Disease: Version SOC Term Classification Code Term Level
    20.0 10038738 - Respiratory, thoracic and mediastinal disorders 10003553 Asthma PT
    Population Age: Children, Under 18 Gender: Male, Female
    Trial protocol: HU (Completed) LT (Completed) PL (Completed) ES (Completed) Outside EU/EEA IT (Completed) RO (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Fri May 09 23:28:27 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA